Timothy P. Clackson

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Robert Yang, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Timothy P. Clackson

Form 4 holding President and CEO, Director

Theseus Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
45,625
Estimated value
$139,156
Report date
01 Mar 2023
Price
$3.05
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Common Stock
Shares / value
70,888
Estimated value
$58,837
Report date
21 Oct 2021
Price
$0.8300
Ownership
The Timothy P. Clackson Irrevocable GST Trust of 2020
Form 4 holding 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Common Stock
Shares / value
20,068
Estimated value
$16,656
Report date
21 Oct 2021
Price
$0.8300
Ownership
Direct
Form 4 holding President and CEO, Director

Theseus Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
273,750
Estimated value
Report date
17 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Forma Therapeutics Holdings, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
14 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Timothy P. Clackson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .